A00895 - Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
New York - 2023-2024 General Assembly
Introduced byEmily E. Gallagher, Albert A. Stirpe, Inez E. Dickens
Last updated over 1 year ago
26 Co-Sponsors
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now